BPG is committed to discovery and dissemination of knowledge
Featured Articles
12/14/2017 4:15:56 AM | Browse: 1086 | Download: 1960
Publication Name World Journal of Gastrointestinal Oncology
Manuscript ID 35154
Country Netherlands
ISSN 1948-5204 (online)
Open Access This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Copyright © The Author(s) 2017. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website http://www.wjgnet.com
Category Oncology
Manuscript Type Retrospective Cohort Study
Article Title Tumor-stroma ratio as prognostic factor for survival in rectal adenocarcinoma: A retrospective cohort study
Manuscript Source Invited Manuscript
All Author List René Scheer, Alexi Baidoshvili, Shorena Zoidze, Marloes AG Elferink, Annefleur EM Berkel, Joost M Klaase and Paulus J van Diest
Funding Agency and Grant Number
Corresponding Author Joost M Klaase, MD, PhD, Surgical Oncologist, Department of Surgery, Medisch Spectrum Twente, PO Box 50.000, Enschede 7500 KA, Netherlands. j.klaase@mst.nl
Key Words Rectal cancer; Adenocarcinoma; Prognosis; Recurrence; Pathology; Tumor-stroma ratio
Core Tip The tumor-stroma ratio (TSR) can be determined accurately on routine histopathological sections by different observers. The TSR has potential as a prognostic factor for survival in surgically treated rectal cancer patients, especially in lymph node negative cases. It could therefore be useful in decision making regarding adjuvant treatment in individual patients.
Publish Date 2017-12-14 00:28
Citation Scheer R, Baidoshvili A, Zoidze S, Elferink MAG, Berkel AEM, Klaase JM, van Diest PJ. Tumor-stroma ratio as prognostic factor for survival in rectal adenocarcinoma: A retrospective cohort study. World J Gastrointest Oncol 2017; 9(12): 466-474
URL http://www.wjgnet.com/1948-5204/full/v9/i12/466.htm
DOI http://dx.doi.org/10.4251/wjgo.v9.i12.466
Full Article (PDF) WJGO-9-466.pdf
Full Article (Word) WJGO-9-466.doc